Tag: Patient Care
-
Study Reconsiders Statin Therapy for Patients in Palliative Care Setting
A multicenter clinical trial suggests that stopping statin medication therapy is safe and maybe beneficial for quality of life and reduction in medication costs for patients in the palliative care setting.
-
Seniors At High Risk For Readmission After Ambulatory Surgery
Older patients who have surgery are much more likely to be readmitted to the hospital than younger patients, regardless of their health before surgery, according to a Northwestern Medicine study.
-
Assessing the Accuracy of Hospital Quality Measurements
An Affordable Care Act program to reduce hospital-acquired conditions more frequently penalized hospitals if they had accreditations, offered advanced services, were major teaching institutions and performed better on other quality measures, showed a Northwestern Medicine study.
-
Three Northwestern Medicine Hospitals Among “America’s Best Hospitals” in 2015 U.S. News Ranking
Northwestern Medicine hospitals continue to earn national recognition as part of the U.S. News & World Report ranking of America’s Best Hospitals.
-
Clinical Trial Shows Efficacy of New Psoriasis Medication
Northwestern Medicine investigators published the results of a clinical trial showing that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care.
-
Joining Forces for Digestive Health
Faculty Stephen Hanauer, MD, and Scott Strong, MD, co-lead Northwestern Medicine’s Digestive Health Center, which aligns physicians, surgeons and other healthcare providers to treat gastrointestinal diseases.
-
Moving Beyond Cancer
The impossible is possible when cancer survivors are monitored by medical professionals who know their specialized needs.
-
Soy Supplements Do Not Improve Asthma
Despite previous findings suggesting a link between soy intake and decreased asthma severity, a new Northwestern Medicine study shows that soy supplements do not improve lung function for patients with asthma.
-
Groundbreaking Findings for Patients with Cystic Fibrosis
Treatment with two medications that target the most common genetic cause of cystic fibrosis improves lung function and lowers the rate of pulmonary exacerbations, according to results from a Northwestern Medicine clinical trial.
-
AQSI Receives Award for Dedication to Improving Healthcare Quality
The Northwestern Medicine Academy for Quality and Safety Improvement received the 2015 Leape Ahead Award from American Association for Physician Leadership.
